<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29413/ABS.2024-9.3.7</article-id><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-4817</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>БИОЛОГИЯ И МЕДИЦИНСКАЯ БИОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>BIOLOGY AND MEDICAL BIOLOGY</subject></subj-group></article-categories><title-group><article-title>Лиганд-ассоциированная активация рецепторов витамина D и потенциальные точки приложения её эффектов в морфогенезе иммунного воспаления: обзор литературы</article-title><trans-title-group xml:lang="en"><trans-title>Ligand-associated activation of  vitamin D receptors and potential points of application of its effects in the morphogenesis of immune inflammation: Literature review</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3665-997X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аблякимов</surname><given-names>Э. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Ablyakimov</surname><given-names>E. T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Аблякимов Эльмар Тофикович – аспирант, ассистент кафедры патологической анатомии с секционным курсом</p><p>295000, г. Симферополь, б-р Ленина, 5-7</p></bio><bio xml:lang="en"><p>Elmar T. Ablyakimov – Postgraduate, Teaching Assistant at the Department of Pathological Anatomy with an Autopsy Course</p><p>Lenina Blvd. 5-7, Simferopol 295000</p></bio><email xlink:type="simple">ablyakimov1995@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5193-4311</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кривенцов</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kriventsov</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кривенцов Максим Андреевич – доктор медицинских наук, заведующий кафедрой патологической анатомии с секционным курсом</p><p>295000, г. Симферополь, б-р Ленина, 5-7</p></bio><bio xml:lang="en"><p>Maxim A. Kriventsov – Dr. Sc. (Med.), Head of the Department of Pathological Anatomy with an Autopsy Course</p><p>Lenina Blvd. 5-7, Simferopol 295000</p></bio><email xlink:type="simple">maksimkgmu@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Медицинский институт имени С.И. Георгиевского,&#13;
ФГАОУ ВО «Крымский федеральный университет имени В.И. Вернадского»</institution></aff><aff xml:lang="en"><institution>Medical Institute named after S.I. Georgievsky, V.I. Vernadsky Crimean Federal University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>22</day><month>07</month><year>2024</year></pub-date><volume>9</volume><issue>3</issue><fpage>79</fpage><lpage>89</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Аблякимов Э.Т., Кривенцов М.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Аблякимов Э.Т., Кривенцов М.А.</copyright-holder><copyright-holder xml:lang="en">Ablyakimov E.T., Kriventsov M.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/4817">https://www.actabiomedica.ru/jour/article/view/4817</self-uri><abstract><p>Согласно последним данным, витамин D относят к веществам с гормональной активностью, который, помимо классических, имеет «неклассические» эффекты, обусловленные наличием сложной взаимосвязи между витамином D и эффекторными клетками иммунной системы. Данная взаимосвязь обусловлена экспрессией рецептора витамина D (VDR, vitamin D receptor) на иммунных клетках, который кодируется соответствующим геном VDR. Рецептор витамина D специфически связывает активную форму витамина D (1,25(OH)2D3). В результате образуется сложный комплекс D3-VDR, который опосредует эффекты витамина D путём образования внутриклеточных сигнальных путей, трансформирующих активность определённых таргетных генов. При этом до конца не ясно, каким образом витамин D реализует свои эффекты на клеточном и рецепторном уровнях. По данным литературы, исследования последних десятилетий выявили значимую роль витамина D и рецепторов иммунных контрольных точек (PD-1 (programmed cell death), PD-L (PD ligand), CTLA (cytotoxic T lymphocyte associated protein)) в аутоиммунных заболеваниях. В этом обзоре излагаются возможные механизмы взаимосвязи данных путей. Более глубокое понимание межклеточных взаимосвязей опосредованных лиганд-ассоциированной активацией рецепторов витамина D, комплекса D3-VDR и рецепторов иммунных контрольных точек (PD-1, PD-L, CTLA) в воспалении может стать основой для разработки новых стратегий диагностики, прогноза и лечения различных заболеваний.</p></abstract><trans-abstract xml:lang="en"><p>According to recent data, vitamin D is classified as a substance with hormonal activity, which, in addition to classical, has “non-classical” effects caused by the complex relationship between vitamin D and effector cells of the immune system. This relationship is based on the expression of the vitamin D receptor (VDR) on immune cells, which is encoded by the corresponding VDR gene. Vitamin D receptor specifically binds the active form of vitamin D (1,25(OH)2D3). As a result, a D3-VDR complex is formed, which mediates the effects of vitamin D through the formation of intracellular signaling pathways that transform the activity of certain target genes. However, it is not entirely clear how vitamin D realizes its effects at the cellular and receptor levels. According to the literature, studies of recent decades have revealed a significant role of vitamin D and immune checkpoint receptors (PD-1 (programmed cell death), PD-L (PD ligand), CTLA (cytotoxic T lymphocyte associated protein)) in autoimmune diseases. This review outlines possible mechanisms for the interconnection of these pathways. A deeper understanding of the intercellular interactions mediated by ligand-associated activation of vitamin D receptors, D3-VDR complex and immune checkpoint receptors (PD-1, PD-L, CTLA) in inflammation may become the basis for the development of new strategies for the diagnosis, prognosis and treatment of various diseases</p></trans-abstract><kwd-group xml:lang="ru"><kwd>витамин D</kwd><kwd>VDR</kwd><kwd>иммунная гранулема</kwd><kwd>белки иммунных контрольных точек PD-1</kwd><kwd>PD-L</kwd><kwd>CTLA</kwd></kwd-group><kwd-group xml:lang="en"><kwd>vitamin D</kwd><kwd>VDR</kwd><kwd>immune granuloma</kwd><kwd>immune checkpoint proteins PD-1</kwd><kwd>PD-L</kwd><kwd>CTLA</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено за счёт гранта Россий- ского научного фонда № 23-25-00161 (https://rscf.ru/ project/23-25-00161)</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Торшин И.Ю. Витамин D. Смена парадигмы; 2-е изд., перераб. и доп.. М.: ГЭОТАР-Медиа; 2021.</mixed-citation><mixed-citation xml:lang="en">Gromova OA, Torshin IYu. Vitamin D. Paradigm change; 2nd edition, revised and enlarged. Moscow: GEOTAR-Media; 2021. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Снопов С.А. Механизмы действия витамина D на иммунную систему. Медицинская иммунология. 2014; 16(6): 499-530. doi: 10.15789/1563-0625-2014-6-499-530</mixed-citation><mixed-citation xml:lang="en">Snopov SA. Mechanisms of vitamin D action on the immune system. Medical Immunology (Russia). 2014; 16(6): 499-530. (In Russ.) doi: 10.15789/1563-0625-2014-6-499-530</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Borba VZ, Vieira JG, Kasamatsu T, Radominski SC, Sato EI, Lazaretti-Castro M. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int. 2009; 20(3): 427-433. doi: 10.1007/s00198-008-0676-1</mixed-citation><mixed-citation xml:lang="en">Borba VZ, Vieira JG, Kasamatsu T, Radominski SC, Sato EI, Lazaretti-Castro M. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int. 2009; 20(3): 427-433. doi: 10.1007/s00198-008-0676-1</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Dankers W, Colin EM, van Hamburg JP, Lubberts E. Vitamin D in autoimmunity: Molecular mechanisms and therapeutic potential. Front Immunol. 2017; 7: 697. doi: 10.3389/fimmu.2016.00697</mixed-citation><mixed-citation xml:lang="en">Dankers W, Colin EM, van Hamburg JP, Lubberts E. Vitamin D in autoimmunity: Molecular mechanisms and therapeutic potential. Front Immunol. 2017; 7: 697. doi: 10.3389/fimmu.2016.00697</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity. 2007; 27(1): 111-122. doi: 10.1016/j.immuni.2007.05.016</mixed-citation><mixed-citation xml:lang="en">Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity. 2007; 27(1): 111-122. doi: 10.1016/j.immuni.2007.05.016</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Paterson AM, Lovitch SB, Sage PT, Juneja VR, Lee Y, Trombley JD, et al. Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity. J Exp Med. 2015; 212(10): 1603-1621. doi: 10.1084/jem.20141030</mixed-citation><mixed-citation xml:lang="en">Paterson AM, Lovitch SB, Sage PT, Juneja VR, Lee Y, Trombley JD, et al. Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity. J Exp Med. 2015; 212(10): 1603-1621. doi: 10.1084/jem.20141030</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Chun RF, Peercy BE, Orwoll ES, Nielson CM, Adams JS, Hewison M. Vitamin D and DBP: The free hormone hypothesis revisited. J Steroid Biochem Mol Biol. 2014; 144(Pt A): 132-137. doi: 10.1016/j.jsbmb.2013.09.012</mixed-citation><mixed-citation xml:lang="en">Chun RF, Peercy BE, Orwoll ES, Nielson CM, Adams JS, Hewison M. Vitamin D and DBP: The free hormone hypothesis revisited. J Steroid Biochem Mol Biol. 2014; 144(Pt A): 132-137. doi: 10.1016/j.jsbmb.2013.09.012</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Miyamoto K, Kesterson RA, Yamamoto H, Taketani Y, Nishiwaki E, Tatsumi S, et al. Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol. 1997; 11(8): 1165-1179. doi: 10.1210/mend.11.8.9951</mixed-citation><mixed-citation xml:lang="en">Miyamoto K, Kesterson RA, Yamamoto H, Taketani Y, Nishiwaki E, Tatsumi S, et al. Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol. 1997; 11(8): 1165-1179. doi: 10.1210/mend.11.8.9951</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Trochoutsou AI, Kloukina V, Samitas K, Xanthou G. Vitamin D in the immune system: Genomic and non-genomic actions. Mini Rev Med Chem. 2015; 15(11): 953-963. doi: 10.2174/13895575156 66150519110830</mixed-citation><mixed-citation xml:lang="en">Trochoutsou AI, Kloukina V, Samitas K, Xanthou G. Vitamin D in the immune system: Genomic and non-genomic actions. Mini Rev Med Chem. 2015; 15(11): 953-963. doi: 10.2174/13895575156 66150519110830</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Pérez E, Bourguet W, Gronemeyer H, de Lera AR. Modulation of RXR function through ligand design. Biochim Biophys Acta. 2012; 1821: 57-69. doi: 10.1016/j.bbalip.2011.04.003</mixed-citation><mixed-citation xml:lang="en">Pérez E, Bourguet W, Gronemeyer H, de Lera AR. Modulation of RXR function through ligand design. Biochim Biophys Acta. 2012; 1821: 57-69. doi: 10.1016/j.bbalip.2011.04.003</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Hu X, Funder JW. The evolution of mineralocorticoid receptors. Mol Endocrinol. 2006; 20(7): 1471-1478. doi: 10.1210/me.2005-0247</mixed-citation><mixed-citation xml:lang="en">Hu X, Funder JW. The evolution of mineralocorticoid receptors. Mol Endocrinol. 2006; 20(7): 1471-1478. doi: 10.1210/me.2005-0247</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hart PH, Gorman S, Finlay-Jones JJ. Modulation of the immune system by UV radiation: More than just the effects of vitamin D? Nat Rev Immunol. 2011; 11(9): 584-596. doi: 10.1038/nri3045</mixed-citation><mixed-citation xml:lang="en">Hart PH, Gorman S, Finlay-Jones JJ. Modulation of the immune system by UV radiation: More than just the effects of vitamin D? Nat Rev Immunol. 2011; 11(9): 584-596. doi: 10.1038/nri3045</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bikle DD, Oda Y, Tu CL, Jiang Y. Novel mechanisms for the vitamin D receptor (VDR) in the skin and in skin cancer. J Steroid Biochem Mol Biol. 2015; 148: 47-51. doi: 10.1016/j.jsbmb.2014.10.017</mixed-citation><mixed-citation xml:lang="en">Bikle DD, Oda Y, Tu CL, Jiang Y. Novel mechanisms for the vitamin D receptor (VDR) in the skin and in skin cancer. J Steroid Biochem Mol Biol. 2015; 148: 47-51. doi: 10.1016/j.jsbmb.2014.10.017</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Doroudi M, Schwartz Z, Boyan BD. Membrane-mediated actions of 1,25-dihydroxy vitamin D3: A review of the roles of phospholipase A2 activating protein and Ca(2+)/calmodulindependent protein kinase II. J Steroid Biochem Mol Biol. 2015; 147: 81-84. doi: 10.1016/j.jsbmb.2014.11.002</mixed-citation><mixed-citation xml:lang="en">Doroudi M, Schwartz Z, Boyan BD. Membrane-mediated actions of 1,25-dihydroxy vitamin D3: A review of the roles of phospholipase A2 activating protein and Ca(2+)/calmodulindependent protein kinase II. J Steroid Biochem Mol Biol. 2015; 147: 81-84. doi: 10.1016/j.jsbmb.2014.11.002</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Mazaira GI, Zgajnar NR, Lotufo CM, Daneri-Becerra C, Sivils JC, Soto OB, et al. Nuclear receptors: A historical perspective. Methods Mol Biol. 2019; 1966: 1-5. doi: 10.1007/978-1-4939-9195-2_1</mixed-citation><mixed-citation xml:lang="en">Mazaira GI, Zgajnar NR, Lotufo CM, Daneri-Becerra C, Sivils JC, Soto OB, et al. Nuclear receptors: A historical perspective. Methods Mol Biol. 2019; 1966: 1-5. doi: 10.1007/978-1-4939-9195-2_1</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Shri Preethi M, Premkumar K, Asha Devi S. Molecular docking study on vitamin D supplements to understand their interaction with VDR-RXRα heterodimer and VDRE of TAGAP gene. J Biomol Struct Dyn. 2022; 24: 1-10. doi: 10.1080/07391102.2022.2114939</mixed-citation><mixed-citation xml:lang="en">Shri Preethi M, Premkumar K, Asha Devi S. Molecular docking study on vitamin D supplements to understand their interaction with VDR-RXRα heterodimer and VDRE of TAGAP gene. J Biomol Struct Dyn. 2022; 24: 1-10. doi: 10.1080/07391102.2022.2114939</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Wierzbicka J, Piotrowska A, Żmijewski MA. The renaissance of vitamin D. Acta Biochim Pol. 2014, 61(4): 679-686.</mixed-citation><mixed-citation xml:lang="en">Wierzbicka J, Piotrowska A, Żmijewski MA. The renaissance of vitamin D. Acta Biochim Pol. 2014, 61(4): 679-686.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Lin L, Zhang L, Li C, Gai Z, Li Y. Vitamin D and vitamin D receptor: New insights in the treatment of hypertension. Curr Protein Pept Sci. 2019; 20(10): 984-995. doi: 10.2174/1389203720 666190807130504</mixed-citation><mixed-citation xml:lang="en">Lin L, Zhang L, Li C, Gai Z, Li Y. Vitamin D and vitamin D receptor: New insights in the treatment of hypertension. Curr Protein Pept Sci. 2019; 20(10): 984-995. doi: 10.2174/1389203720 666190807130504</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Adams JS. Update in vitamin D. J Clin Endocrinol Metab. 2010; 95: 471-478. doi: 10.1210/jc.2009-1773</mixed-citation><mixed-citation xml:lang="en">Adams JS. Update in vitamin D. J Clin Endocrinol Metab. 2010; 95: 471-478. doi: 10.1210/jc.2009-1773</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Chung C, Silwal P, Kim I, Modlin RL, Jo EK. Vitamin Dcathelicidin axis: At the crossroads between protective immunity and pathological inflammation during infection. Immune Netw. 2020; 20(2): e12. doi: 10.4110/in.2020.20.e12</mixed-citation><mixed-citation xml:lang="en">Chung C, Silwal P, Kim I, Modlin RL, Jo EK. Vitamin Dcathelicidin axis: At the crossroads between protective immunity and pathological inflammation during infection. Immune Netw. 2020; 20(2): e12. doi: 10.4110/in.2020.20.e12</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Alroy I, Towers TL, Freedman LP. Transcriptional repression of the interleukin-2 gene by vitamin D3: Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol. 1995; 15(10): 5789-5799. doi: 10.1128/MCB.15.10.5789</mixed-citation><mixed-citation xml:lang="en">Alroy I, Towers TL, Freedman LP. Transcriptional repression of the interleukin-2 gene by vitamin D3: Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol. 1995; 15(10): 5789-5799. doi: 10.1128/MCB.15.10.5789</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Xin Y, Wang H, Wang Y, Xu W, Teng G, Han F, et al. CCL20 mediates the anti-tumor effect of vitamin D3 in p38MAPK/NF-κB signaling in colitis-associated carcinogenesis. Eur J Cancer Prev. 2021; 30(1): 76-83. doi: 10.1097/CEJ.0000000000000582</mixed-citation><mixed-citation xml:lang="en">Xin Y, Wang H, Wang Y, Xu W, Teng G, Han F, et al. CCL20 mediates the anti-tumor effect of vitamin D3 in p38MAPK/NF-κB signaling in colitis-associated carcinogenesis. Eur J Cancer Prev. 2021; 30(1): 76-83. doi: 10.1097/CEJ.0000000000000582</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Van Belle TL, Gysemans C, Mathieu C. Vitamin D in autoimmune, infectious and allergic diseases: A vital player? Best Pract Res Clin Endocrinol Metab. 2011; (25): 617-632. doi: 10.1016/j.beem.2011.04.009</mixed-citation><mixed-citation xml:lang="en">Van Belle TL, Gysemans C, Mathieu C. Vitamin D in autoimmune, infectious and allergic diseases: A vital player? Best Pract Res Clin Endocrinol Metab. 2011; (25): 617-632. doi: 10.1016/j.beem.2011.04.009</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Vieira VM, Hart JE, Webster TF, Weinberg J, Puett R, Laden F, et al. Association between residences in U.S. northern latitudes and rheumatoid arthritis: A spatial analysis of the Nurses’ Health Study. Environ Health Perspect. 2010; 118(7): 957-961. doi: 10.1289/ehp.0901861</mixed-citation><mixed-citation xml:lang="en">Vieira VM, Hart JE, Webster TF, Weinberg J, Puett R, Laden F, et al. Association between residences in U.S. northern latitudes and rheumatoid arthritis: A spatial analysis of the Nurses’ Health Study. Environ Health Perspect. 2010; 118(7): 957-961. doi: 10.1289/ehp.0901861</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Terrier B, Derian N, Schoindre Y, Chaara W, Geri G, Zahr N, et al. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res Ther. 2012; 14(5): R221. doi: 10.1186/ar4060</mixed-citation><mixed-citation xml:lang="en">Terrier B, Derian N, Schoindre Y, Chaara W, Geri G, Zahr N, et al. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res Ther. 2012; 14(5): R221. doi: 10.1186/ar4060</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Prietl B, Theiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013; 5(7): 2502-2521. doi: 10.3390/nu5072502</mixed-citation><mixed-citation xml:lang="en">Prietl B, Theiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013; 5(7): 2502-2521. doi: 10.3390/nu5072502</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">L Bishop E, Ismailova A, Dimeloe S, Hewison M, White JH. Vitamin D and immune regulation: Antibacterial, antiviral, anti-inflammatory. JBMR Plus. 2020; 5(1): e10405. doi: 10.1002/jbm4.10405</mixed-citation><mixed-citation xml:lang="en">L Bishop E, Ismailova A, Dimeloe S, Hewison M, White JH. Vitamin D and immune regulation: Antibacterial, antiviral, anti-inflammatory. JBMR Plus. 2020; 5(1): e10405. doi: 10.1002/jbm4.10405</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Wang T, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, et al. 1,25-dihy-droxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004; 173: 2909-2912. doi: 10.4049/jimmunol.173.5.2909</mixed-citation><mixed-citation xml:lang="en">Wang T, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, et al. 1,25-dihy-droxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004; 173: 2909-2912. doi: 10.4049/jimmunol.173.5.2909</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006; 311: 1770-1773. doi: 10.1126/science.1123933</mixed-citation><mixed-citation xml:lang="en">Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006; 311: 1770-1773. doi: 10.1126/science.1123933</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Baeke F, Korf H, Overbergh L, Van Etten E, Verstuyf A, Gysemans C, et al. Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system. J Steroid Biochem Mol Biol. 2010; 121(1-2): 221-227. doi: 10.1016/j.jsbmb.2010.03.037</mixed-citation><mixed-citation xml:lang="en">Baeke F, Korf H, Overbergh L, Van Etten E, Verstuyf A, Gysemans C, et al. Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system. J Steroid Biochem Mol Biol. 2010; 121(1-2): 221-227. doi: 10.1016/j.jsbmb.2010.03.037</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, Eliopoulos AG, et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol. 2003; (170): 5382-5390. doi: 10.4049/jimmunol.170.11.5382</mixed-citation><mixed-citation xml:lang="en">Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, Eliopoulos AG, et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol. 2003; (170): 5382-5390. doi: 10.4049/jimmunol.170.11.5382</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Cassetta L, Cassol E, Poli G. Macrophage polarization in health and disease. Sci World J. 2011; (11): 2391-2402. doi: 10.1100/2011/213962</mixed-citation><mixed-citation xml:lang="en">Cassetta L, Cassol E, Poli G. Macrophage polarization in health and disease. Sci World J. 2011; (11): 2391-2402. doi: 10.1100/2011/213962</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Van Etten E, Stoffels K, Gysemans C, Mathieu C, Overbergh L. Regulation of vitamin D homeostasis: Implications for the immune system. Nutr Rev. 2008; 66: 125-134. doi: 10.1111/j.1753-4887.2008.00096.x</mixed-citation><mixed-citation xml:lang="en">Van Etten E, Stoffels K, Gysemans C, Mathieu C, Overbergh L. Regulation of vitamin D homeostasis: Implications for the immune system. Nutr Rev. 2008; 66: 125-134. doi: 10.1111/j.1753-4887.2008.00096.x</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Kissa M, Czimmerer Z, Nagy L. The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology. J Allergy Clin Immunol. 2013; 132(2): 264-286. doi: 10.1016/j. jaci.2013.05.044</mixed-citation><mixed-citation xml:lang="en">Kissa M, Czimmerer Z, Nagy L. The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology. J Allergy Clin Immunol. 2013; 132(2): 264-286. doi: 10.1016/j. jaci.2013.05.044</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Wafa N, Lamia Y-D, Mourad A. Vitamin D3 enhances bactericidal activity of macrophage against Pseudomonas aeruginosa. Int Immunopharmacol. 2016; 30: 94-101. doi: 10.1016/j.intimp.2015.11.033</mixed-citation><mixed-citation xml:lang="en">Wafa N, Lamia Y-D, Mourad A. Vitamin D3 enhances bactericidal activity of macrophage against Pseudomonas aeruginosa. Int Immunopharmacol. 2016; 30: 94-101. doi: 10.1016/j.intimp.2015.11.033</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Eagar TN, Tompkins SM, Miller SD. Helper T-cell subsets and control of the inflammatory response. Clinical Immunology. Mosby, London, UK; 2001: 16.1-16.12.</mixed-citation><mixed-citation xml:lang="en">Eagar TN, Tompkins SM, Miller SD. Helper T-cell subsets and control of the inflammatory response. Clinical Immunology. Mosby, London, UK; 2001: 16.1-16.12.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Prietl B, Theiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013; 5(7): 2502-2521. doi: 10.3390/nu5072502</mixed-citation><mixed-citation xml:lang="en">Prietl B, Theiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013; 5(7): 2502-2521. doi: 10.3390/nu5072502</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Lopez DV, Al-Jaberi FAH, Woetmann A, Ødum N, Bonefeld CM, Kongsbak-Wismann M, et al. Macrophages control the bioavailability of vitamin D and vitamin D-regulated T cell responses. Front Immunol. 2021; 12: 722806. doi: 10.3389/fimmu.2021.722806</mixed-citation><mixed-citation xml:lang="en">Lopez DV, Al-Jaberi FAH, Woetmann A, Ødum N, Bonefeld CM, Kongsbak-Wismann M, et al. Macrophages control the bioavailability of vitamin D and vitamin D-regulated T cell responses. Front Immunol. 2021; 12: 722806. doi: 10.3389/fimmu.2021.722806</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Maldonado RA, von Andrian UH. How tolerogenic dendritic cells induce regulatory T cells. Adv Immunol. 2010; (108): 111-165. doi: 10.1016/B978-0-12-380995-7.00004-5</mixed-citation><mixed-citation xml:lang="en">Maldonado RA, von Andrian UH. How tolerogenic dendritic cells induce regulatory T cells. Adv Immunol. 2010; (108): 111-165. doi: 10.1016/B978-0-12-380995-7.00004-5</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Kim S, Park GY, Park JS, Park J, Hong H, Lee Y. Regulation of positive and negative selection and TCR signaling during thymic T cell development by capicua. Elife. 2021; 10: e71769. doi: 10.7554/eLife.71769</mixed-citation><mixed-citation xml:lang="en">Kim S, Park GY, Park JS, Park J, Hong H, Lee Y. Regulation of positive and negative selection and TCR signaling during thymic T cell development by capicua. Elife. 2021; 10: e71769. doi: 10.7554/eLife.71769</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Tuzlak S, Dejean AS, Iannacone M, Quintana FJ, Waisman A, Ginhoux F, et al. Repositioning TH cell polarization from single cytokines to complex help. Nat Immunol. 2021; 22: 1210-1217. doi: 10.1038/s41590-021-01009-w</mixed-citation><mixed-citation xml:lang="en">Tuzlak S, Dejean AS, Iannacone M, Quintana FJ, Waisman A, Ginhoux F, et al. Repositioning TH cell polarization from single cytokines to complex help. Nat Immunol. 2021; 22: 1210-1217. doi: 10.1038/s41590-021-01009-w</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, Heinrich JM, et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity. 2011; 34(4): 566-578. doi: 10.1016/j.immuni.2011.03.018</mixed-citation><mixed-citation xml:lang="en">Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, Heinrich JM, et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity. 2011; 34(4): 566-578. doi: 10.1016/j.immuni.2011.03.018</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10 secreting type-1 regulatory T cells in rodents and humans. Immunol Rev. 2006; 212: 28-50. doi: 10.1111/j.0105-2896.2006.00420.x</mixed-citation><mixed-citation xml:lang="en">Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10 secreting type-1 regulatory T cells in rodents and humans. Immunol Rev. 2006; 212: 28-50. doi: 10.1111/j.0105-2896.2006.00420.x</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, Hewison M, et al. 1,25-dihydxroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol. 2009; 183(9): 5458-5467. doi: 10.4049/jimmunol.0803217</mixed-citation><mixed-citation xml:lang="en">Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, Hewison M, et al. 1,25-dihydxroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol. 2009; 183(9): 5458-5467. doi: 10.4049/jimmunol.0803217</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Kumagai S, Koyama S, Itahashi K, Tanegashima T, Lin YT, Togashi Y, et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer Cell. 2022; 40(2): 201-218.e9. doi: 10.1016/j.ccell.2022.01.001</mixed-citation><mixed-citation xml:lang="en">Kumagai S, Koyama S, Itahashi K, Tanegashima T, Lin YT, Togashi Y, et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer Cell. 2022; 40(2): 201-218.e9. doi: 10.1016/j.ccell.2022.01.001</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Almanan MA, Raynor J, Chougnet C, Salamonis N, Amarachintha S, Steinbrecher K, et al. Type 1 regulatory T cells (Tr1) homeostasis and function in aging. J Immunol. 2017; 198(Suppl 1): 154.10.</mixed-citation><mixed-citation xml:lang="en">Almanan MA, Raynor J, Chougnet C, Salamonis N, Amarachintha S, Steinbrecher K, et al. Type 1 regulatory T cells (Tr1) homeostasis and function in aging. J Immunol. 2017; 198(Suppl 1): 154.10.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O’Garra A. 1α,25-dihydroxyvitamin D3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol. 2001; 167(1): 4974-4980. doi: 10.4049/jimmunol.167.9.4974</mixed-citation><mixed-citation xml:lang="en">Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O’Garra A. 1α,25-dihydroxyvitamin D3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol. 2001; 167(1): 4974-4980. doi: 10.4049/jimmunol.167.9.4974</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Chauss D, Freiwald T, McGregor R, Yan B, Wang L, Nova-Lamperti E, et al. Autocrine vitamin D signaling switches off proinflammatory programs of TH1 cells. Nat Immunol. 2022; 23(1): 62-74. doi: 10.1038/s41590-021-01080-3</mixed-citation><mixed-citation xml:lang="en">Chauss D, Freiwald T, McGregor R, Yan B, Wang L, Nova-Lamperti E, et al. Autocrine vitamin D signaling switches off proinflammatory programs of TH1 cells. Nat Immunol. 2022; 23(1): 62-74. doi: 10.1038/s41590-021-01080-3</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Topilski I, Flaishon L, Naveh Y, Harmelin A, Levo Y, Shachar I. The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cell in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur J Immunol. 2004; 34(4): 1068-1074. doi: 10.1002/eji.200324532</mixed-citation><mixed-citation xml:lang="en">Topilski I, Flaishon L, Naveh Y, Harmelin A, Levo Y, Shachar I. The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cell in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur J Immunol. 2004; 34(4): 1068-1074. doi: 10.1002/eji.200324532</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Fisher SA, Rahimzadeh M, Brierley C, Gration B, Doree C, Kimber CE, et al. The role of vitamin D in increasing circulating T regulatory cell numbers and modulating T regulatory cell phenotypes in patients with inflammatory disease or in healthy volunteers: A systematic review. PLoS One. 2019; 14(9): e0222313. doi: 10.1371/journal.pone.0222313</mixed-citation><mixed-citation xml:lang="en">Fisher SA, Rahimzadeh M, Brierley C, Gration B, Doree C, Kimber CE, et al. The role of vitamin D in increasing circulating T regulatory cell numbers and modulating T regulatory cell phenotypes in patients with inflammatory disease or in healthy volunteers: A systematic review. PLoS One. 2019; 14(9): e0222313. doi: 10.1371/journal.pone.0222313</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human cell differentiation. J Immunol. 2007; 179(3): 1634-1647. doi: 10.4049/jimmunol.179.3.1634</mixed-citation><mixed-citation xml:lang="en">Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human cell differentiation. J Immunol. 2007; 179(3): 1634-1647. doi: 10.4049/jimmunol.179.3.1634</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Muller K, Bendtzen K. Inhibition of human T lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3. Differential effects on CD45RA+ and CD45R0+ cells. Autoimmunity. 1992; 14(1): 37-43.</mixed-citation><mixed-citation xml:lang="en">Muller K, Bendtzen K. Inhibition of human T lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3. Differential effects on CD45RA+ and CD45R0+ cells. Autoimmunity. 1992; 14(1): 37-43.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Cai H, Liu G, Zhong J, Zheng K, Xiao H, Li C, et al. Immune checkpoints in viral infections. Viruses. 2020; 12(9): 1051. doi: 10.3390/v12091051</mixed-citation><mixed-citation xml:lang="en">Cai H, Liu G, Zhong J, Zheng K, Xiao H, Li C, et al. Immune checkpoints in viral infections. Viruses. 2020; 12(9): 1051. doi: 10.3390/v12091051</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Greaves P, Gribben JG. The role of B7 family molecules in hematologic malignancy. Blood. 2013; 121(5): 734-744. doi: 10.1182/blood-2012-10-3855</mixed-citation><mixed-citation xml:lang="en">Greaves P, Gribben JG. The role of B7 family molecules in hematologic malignancy. Blood. 2013; 121(5): 734-744. doi: 10.1182/blood-2012-10-3855</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 2008; 26(1): 677-704. doi: 10.1146/annurev.immunol.26.021607.090331</mixed-citation><mixed-citation xml:lang="en">Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 2008; 26(1): 677-704. doi: 10.1146/annurev.immunol.26.021607.090331</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol. 2005; 23: 515-548. doi: 10.1146/annurev. immunol.23.021704.115611</mixed-citation><mixed-citation xml:lang="en">Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol. 2005; 23: 515-548. doi: 10.1146/annurev. immunol.23.021704.115611</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Liu J, Hamrouni A, Wolowiec D, Coiteux V, Kuliczkowski K, Hetuin D, et al. Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-gamma and TLR ligands via a MyD88-, TRAF6-, and MEKdependent pathway. Blood. 2007; 110(1): 296-304. doi: 10.1182/blood-2006-10-051482</mixed-citation><mixed-citation xml:lang="en">Liu J, Hamrouni A, Wolowiec D, Coiteux V, Kuliczkowski K, Hetuin D, et al. Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-gamma and TLR ligands via a MyD88-, TRAF6-, and MEKdependent pathway. Blood. 2007; 110(1): 296-304. doi: 10.1182/blood-2006-10-051482</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Yokosuka T, Takamatsu M, Kobayashi-Imanishiet W, Hashimoto-Tane A, Azuma M, Saito T. Programmed cell death 1 forms negative costimulatorymicroclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J Exp Med. 2012; 209(6): 1201-1217. doi: 10.1084/jem.20112741</mixed-citation><mixed-citation xml:lang="en">Yokosuka T, Takamatsu M, Kobayashi-Imanishiet W, Hashimoto-Tane A, Azuma M, Saito T. Programmed cell death 1 forms negative costimulatorymicroclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J Exp Med. 2012; 209(6): 1201-1217. doi: 10.1084/jem.20112741</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Wolchok JD, Neyns B, Linette G, Negrier S, Lutzky J, Thomas L, et al. Ipilimumabmonotherapy in patients with pretreated advanced melanoma: A randomised, double-blind, multicentre, phase 2, dose-ranging study. Lancet Oncology. 2010; 11(2): 155-164. doi: 10.1016/s1470-2045(09)70334-1</mixed-citation><mixed-citation xml:lang="en">Wolchok JD, Neyns B, Linette G, Negrier S, Lutzky J, Thomas L, et al. Ipilimumabmonotherapy in patients with pretreated advanced melanoma: A randomised, double-blind, multicentre, phase 2, dose-ranging study. Lancet Oncology. 2010; 11(2): 155-164. doi: 10.1016/s1470-2045(09)70334-1</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Olsson C, Riebeck K, Dohlsten M, Michaelsson E. CTLA-4 ligation suppresses CD28-induced NF-kB and AP-1 activity in mouse T cell blasts. J Biol Chem. 1999; 274(20): 14400-14405. doi: 10.1074/jbc.274.20.14400</mixed-citation><mixed-citation xml:lang="en">Olsson C, Riebeck K, Dohlsten M, Michaelsson E. CTLA-4 ligation suppresses CD28-induced NF-kB and AP-1 activity in mouse T cell blasts. J Biol Chem. 1999; 274(20): 14400-14405. doi: 10.1074/jbc.274.20.14400</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Zaulkffali AS, MdRazip NN, Syed Alwi SS, AbdJalil A, AbdMutalib MS, Gopalsamy B, et al. Vitamins D and E stimulate the PI3K-AKT signalling pathway in insulin-resistant SK-N-SH neuronal cells. Nutrients. 2019; 11(10): 2525. doi: 10.3390/nu11102525</mixed-citation><mixed-citation xml:lang="en">Zaulkffali AS, MdRazip NN, Syed Alwi SS, AbdJalil A, AbdMutalib MS, Gopalsamy B, et al. Vitamins D and E stimulate the PI3K-AKT signalling pathway in insulin-resistant SK-N-SH neuronal cells. Nutrients. 2019; 11(10): 2525. doi: 10.3390/nu11102525</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol. 2007; 8(3): 239-245. doi: 10.1038/ni1443</mixed-citation><mixed-citation xml:lang="en">Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol. 2007; 8(3): 239-245. doi: 10.1038/ni1443</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Cao L, Che X, Qiu X, Li Z, Yang B, Wang S, et al. M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer. Cancer Mana Res. 2019; 11: 6125-6138. doi: 10.2147/CMAR.S199832</mixed-citation><mixed-citation xml:lang="en">Cao L, Che X, Qiu X, Li Z, Yang B, Wang S, et al. M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer. Cancer Mana Res. 2019; 11: 6125-6138. doi: 10.2147/CMAR.S199832</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Selenko-Gebauer N, Majdic O, Szekeres A, Höfler G, Guthann E, Korthäuer U, et al. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J Immunol. 2003; 17(7): 3637-3644. doi: 10.4049/jimmunol.170.7.3637</mixed-citation><mixed-citation xml:lang="en">Selenko-Gebauer N, Majdic O, Szekeres A, Höfler G, Guthann E, Korthäuer U, et al. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J Immunol. 2003; 17(7): 3637-3644. doi: 10.4049/jimmunol.170.7.3637</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Aygun H. Vitamin D can reduce severity in COVID-19 through regulation of PD-L1. Naunyn Schmiedebergs Arch Pharmacol. 2022; 395(4): 487-494. doi: 10.1007/s00210-022-02210-w</mixed-citation><mixed-citation xml:lang="en">Aygun H. Vitamin D can reduce severity in COVID-19 through regulation of PD-L1. Naunyn Schmiedebergs Arch Pharmacol. 2022; 395(4): 487-494. doi: 10.1007/s00210-022-02210-w</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Pishesha N, Harmand TJ, Ploegh HL. A guide to antigen processing and presentation. Nat Rev Immunol. 2022; 22: 751-764. doi: 10.1038/s41577-022-00707-2</mixed-citation><mixed-citation xml:lang="en">Pishesha N, Harmand TJ, Ploegh HL. A guide to antigen processing and presentation. Nat Rev Immunol. 2022; 22: 751-764. doi: 10.1038/s41577-022-00707-2</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Spector WG. The granulomatous inflammatory exudate. Int Rev Exp Pathol. 1969; 8: 1-55.</mixed-citation><mixed-citation xml:lang="en">Spector WG. The granulomatous inflammatory exudate. Int Rev Exp Pathol. 1969; 8: 1-55.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Adams DO. The structure of mononuclear phagocytes differentiating in vivo: I. Sequential fine and histologic studies of the effect of Bacillus Calmette-Guerin (BCG). Am J Pathol. 1974; 76: 17-48.</mixed-citation><mixed-citation xml:lang="en">Adams DO. The structure of mononuclear phagocytes differentiating in vivo: I. Sequential fine and histologic studies of the effect of Bacillus Calmette-Guerin (BCG). Am J Pathol. 1974; 76: 17-48.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Dandekar RC, Kingaonkar AV, Dhabekar GS. Role of macrophages in malignancy. Ann Maxillofac Surg. 2011; 1(2): 150-154. doi: 10.4103/2231-0746.92782</mixed-citation><mixed-citation xml:lang="en">Dandekar RC, Kingaonkar AV, Dhabekar GS. Role of macrophages in malignancy. Ann Maxillofac Surg. 2011; 1(2): 150-154. doi: 10.4103/2231-0746.92782</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Gordon SR, Maute RL, Dulken BW, Hutter G, George BM, McCracken MN, et al. PD-1 expression by tumourassociated macrophages inhibits phagocytosis and tumour immunity. Nature. 2017; 545(7655): 495-499. doi: 10.1038/nature22396</mixed-citation><mixed-citation xml:lang="en">Gordon SR, Maute RL, Dulken BW, Hutter G, George BM, McCracken MN, et al. PD-1 expression by tumourassociated macrophages inhibits phagocytosis and tumour immunity. Nature. 2017; 545(7655): 495-499. doi: 10.1038/nature22396</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">McNally AK, Anderson JM. Phenotypic expression in human monocyte-derived interleukin-4-induced foreign body giant cells and macrophages in vitro: Dependence on material surface properties. J Biomed Mater Res A. 2015; 103: 1380-1390. doi: 10.1002/jbm.a.35280</mixed-citation><mixed-citation xml:lang="en">McNally AK, Anderson JM. Phenotypic expression in human monocyte-derived interleukin-4-induced foreign body giant cells and macrophages in vitro: Dependence on material surface properties. J Biomed Mater Res A. 2015; 103: 1380-1390. doi: 10.1002/jbm.a.35280</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Van den Bossche J, Bogaert P, van Hengel J, Guerin CJ, Berx G, et al. Alternatively activated macrophages engage in homotypic and heterotypic interactions through IL-4 and polyamineinduced E-cadherin/catenin complexes. Blood. 2009; 114: 4664-4674. doi: 10.1182/blood-2009-05-221598</mixed-citation><mixed-citation xml:lang="en">Van den Bossche J, Bogaert P, van Hengel J, Guerin CJ, Berx G, et al. Alternatively activated macrophages engage in homotypic and heterotypic interactions through IL-4 and polyamineinduced E-cadherin/catenin complexes. Blood. 2009; 114: 4664-4674. doi: 10.1182/blood-2009-05-221598</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Pagán AJ, Ramakrishnan L. The formation and function of granulomas. Annu Rev Immunol. 2018; 36: 639-665. doi: 10.1146/annurev-immunol-032712-100022</mixed-citation><mixed-citation xml:lang="en">Pagán AJ, Ramakrishnan L. The formation and function of granulomas. Annu Rev Immunol. 2018; 36: 639-665. doi: 10.1146/annurev-immunol-032712-100022</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Mayne C, Spanier J, Relland L, Williams CB, Hayes CE. 1,25-dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. Eur J Immunol. 2011; 41: 822-832. doi: 10.1002/eji.201040632</mixed-citation><mixed-citation xml:lang="en">Mayne C, Spanier J, Relland L, Williams CB, Hayes CE. 1,25-dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. Eur J Immunol. 2011; 41: 822-832. doi: 10.1002/eji.201040632</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Lin PL, Myers A, Smith L, Bigbee C, Bigbee M, Fuhrman C, et al. Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. Arthritis Rheum. 2010; 62: 340-50. doi: 10.1002/art.27271</mixed-citation><mixed-citation xml:lang="en">Lin PL, Myers A, Smith L, Bigbee C, Bigbee M, Fuhrman C, et al. Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. Arthritis Rheum. 2010; 62: 340-50. doi: 10.1002/art.27271</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Muscettola M, Grasso G. Effect of 1,25-dihydroxyvitamin D3 on interferon gamma production in vitro. Immunol Lett. 1988; 17: 121-124. doi: 10.1016/0165-2478(88)90079-x</mixed-citation><mixed-citation xml:lang="en">Muscettola M, Grasso G. Effect of 1,25-dihydroxyvitamin D3 on interferon gamma production in vitro. Immunol Lett. 1988; 17: 121-124. doi: 10.1016/0165-2478(88)90079-x</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Ohta M, Okabe T, Ozawa K, Urabe A, Takaku F. In vitro formation of macrophage-epithelioid cells and multinucleated giant cells by 1 alpha,25-dihydroxy vitamin D3 from human circulating monocytes. Ann N Y Acad Sci. 1986; 465: 211-220. doi: 10.1111/j.1749-6632.1986.tb18497.x</mixed-citation><mixed-citation xml:lang="en">Ohta M, Okabe T, Ozawa K, Urabe A, Takaku F. In vitro formation of macrophage-epithelioid cells and multinucleated giant cells by 1 alpha,25-dihydroxy vitamin D3 from human circulating monocytes. Ann N Y Acad Sci. 1986; 465: 211-220. doi: 10.1111/j.1749-6632.1986.tb18497.x</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Penna G, Adorini L. 1α,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 2000; 164: 2405-2411. doi: 10.4049/jimmunol.164.5.2405</mixed-citation><mixed-citation xml:lang="en">Penna G, Adorini L. 1α,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 2000; 164: 2405-2411. doi: 10.4049/jimmunol.164.5.2405</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
